Endoscopic third ventriculostomy is now a popular alternative to ventricular shunt placement for the treatment of obstructive hydrocephalus in children, because there have been significant advances in this field, such as the use of endoscopes, fiberoptic devices, and other instruments. [1] [2] [3] 10 In particular, ETV has become the procedure of choice for the management of triventricular hydrocephalus from aqueductal stenosis at most centers because this procedure provides a more physiological and anatomical diversion pathway for CSF. It obviates the needs to place a foreign body such as a ventricular shunt, thus avoiding shunt-related complications such as malfunction, infection, and overdrainage. Several authors have recommended ETV for the treatment of hydrocephalus arising from various causes such as brain tumors, myelomeningoceles, meningitis, hemorrhage, and infection. Nevertheless, the outcome of ETV was reported to depend on the origin of each case of hydrocephalus and the institution in which it was treated. In this study we evaluate the outcomes and efficacy of ETV in our population of children with intracranial tumors.
was performed. In cases in which the CSF flow study showed a patent third ventriculostomy, however, a VP shunt was inserted.
RESULTS
Fifty ETVs were attempted in 43 patients (Table 1) . Twenty-seven of the 43 patients were shunt independent at the time of last follow-up evaluation (mean 24.6 months). Thirteen of them required VP shunt placement following ETV. Two procedures were abandoned because of anatomical distortion. Both of these patients had obstructive hydrocephalus arising from a thalamic tumor.
Of the 32 patients who underwent a successful ETV, 12 had VP shunt placement prior to undergoing ETV ( Table 2 ). The shunt was usually externalized 1 day before ETV and the height of the drain was progressively elevated with or without ICP monitoring to increase the size of the ventricles. The shunt was usually removed at the time of the ETV procedure. An external ventricular catheter was placed if patients were experiencing moderate to severe symptoms or a significant increase in ICP the day before the procedure.
Outcomes were compared in patients who had undergone previous VP shunt insertion and in those who had not, regardless of tumor location. Seven of 12 patients who had previously received a VP shunt achieved long-term successful outcomes, compared with 21 of 31 patients who had not undergone this treatment previously. Although patients who had undergone a previous shunt placement had lower longterm success rates after ETVs compared with those who had no history of shunt treatment (58% compared with 68%), the difference was not statistically significant (p Ͼ 0.05).
There were eight repeated ETVs in six patients (Table 3) . This included three patients with posterior fossa tumors, two with midbrain/tectal tumors, and one with a third ventricular tumor. The mean interval to repeated ETV was 25 months (range 2.3-48 months). Among the six patients who underwent repeated ETV, all were shunt independent at the last follow-up visit. An MR imaging/CSF flow study was performed in these patients before repeating the ETV.
Follow-Up Evaluation
Clinical follow-up data were available to evaluate outcome in all 43 patients. The follow-up period ranged from 3 to 78 months (mean 24.6 months). The overall success rate for patients with brain tumors was 69.8%. All patients in whom treatment failed presented with symptoms and signs related to increased ICP. Of the 13 patients who needed a ventricular shunt after ETV, five required the device within 7 days after undergoing ETV. The median interval to placement of a ventricular shunt was 29.5 days (range 3-187 days).
Procedure-Related Complications
For the 43 ETVs performed, there were no deaths related to the procedure. Nine patients (20.9%) in this series had intra-and/or postoperative complications (Table 4) . Three cases of intraoperative venous bleeding were controlled by continuous irrigation during surgery. Two patients experienced a temporary decrease in their level of consciousness with no pathological finding on postoperative imaging studies. Other complications that the authors observed in this series included temporary diabetes insipidus, infection, and temporary limitation of ocular palsy.
DISCUSSION
Authors of several clinical studies have described the effectiveness of ETV in select patients with obstructive hydrocephalus. 1, 3, 6, 8, 21 The ETV was initially considered to be an alternative procedure to ventricular shunt insertion for triventricular hydrocephalus arising from aqueductal stenosis. It has also been recommended as the initial management for hydrocephalus from other causes. Nevertheless, despite these optimistic reports, the outcomes for ETV vary from 23 to 100% success rates, depending on the institution, definition of failure, origin of hydrocephalus, indication, and follow-up period. 10, 14, 16, 20 P. Ray, et al. 
Clinical Outcome
The definition of ETV failure has yet to be clearly established or agreed on among neurosurgeons and institutions. Several methods had been tried to evaluate the success of ETV, such as resolution of clinical symptoms and radiological findings. 3, 8, 10, 13, 20 Some authors, however, believe that success of ETV should be defined as shunt independence. Using this definition, 27 of 43 patients (excluding one in whom the procedure was aborted) were shunt independent after ETV. The overall long-term success rate for ETV in this series was 69.8%, with a mean follow-up duration of 24.6 months. This outcome is similar to that reported recently in other publications. Hopf, et al., 8 reported an overall success rate of 76% in 100 consecutive procedures, and Cinalli, et al., 3 reported a 72% success rate in 213 cases of hydrocephalus treated with ETV.
In our series, the best results (100% success) were obtained in the cases in which there was obstruction at or around the level of the sylvian aqueduct, such as midbrain/tectal tumor (four patients), pineal region tumor (three patients), and third ventricular tumor (two patients). Hopf, et al., 8 reported a high success rate with ETV in patients with space-occupying lesions of the midbrain and posterior fossa (83 and 79%, respectively). Scarrow, et al., 17 reported similar results, with a 94% success rate for tectal/pineal masses. These patients had been considered classic candidates for third ventriculostomy. Patients with hydrocephalus from the aforementioned causes had open subarachnoid spaces and an intact CSF absorption mechanism. Therefore, these results support the theoretical basis of ETV.
Despite these outstanding results, however, a certain number of patients with ideal indications for ETV still had poor outcomes in our series. The reason for these failures of ETV in the group with classic indications is not yet clear. Proposed hypotheses have been that an undetectable deficiency in CSF absorption may exist at the arachnoid villi level 1 or that CSF flow from the third ventricle is blocked in the prepontine cistern by the Liliequist membrane (an arachnoidal sheet composed of three leaves extending from the upper border of the dorsum sellae to the anterior edge of the mammillary bodies). Buxton, et al., 2 stated that to achieve a successful ETV, not only must the floor of the third ventricle be opened, but also the Liliequist membrane.
The underlying causes of hydrocephalus that yielded less favorable success rates for ETV in this series were posterior fossa and thalamic tumors. Low success rates (0-63%) in other recent articles support our outcomes for ETV performed to treat these causes of hydrocephalus.
2,8-10,17
The management of hydrocephalus associated with posterior fossa tumors has been a longstanding controversy. Use of ETV in patients with posterior fossa tumors has been reported before or after tumor resection, and its successful outcome has been between 50 and 85%. 1, 16, 17 In the past, some authors advocated preoperative placement of a permanent ventricular shunt before the definitive tumor resection because this decreased the morbidity and mortality rates associated with the tumor resection. 15 Nevertheless, the value of a precraniotomy ventricular shunt was questioned by others because some patients' postoperative courses were complicated by upward herniation, intratumoral hemorrhage, and infection. In addition, early surgery and the use of corticosteroid agents have decreased the morbidity and mortality rates with no need for a precraniotomy shunt placement. 4, 5, 11 Other groups advocate ETV prior to all posterior fossa surgery. It has been reported, however, that only 17 to 40% of patients with posterior fossa tumors will require placement of a shunt after tumor resection. Furthermore, postresection CSF shunting was addressed in patients who had early and aggressive resections. 11 It was determined that only 15.5% of patients required shunts. Several authors have asserted that the need for a postoperative shunt after tumor resection is significantly increased in younger children, patients with midline tumors, subtotal resection of tumor, preoperative hydrocephalus, pseudomeningocele formation after tumor resection, or CSF infection. 4, 11 Our data showed that six (66.6%) of nine of our patients with posterior fossa tumors required shunt placement after ETV. This supports our approach of early surgery rather than initial ETV followed by surgery in children with posterior fossa tumors. We then perform an ETV in symptomatic patients, but cautiously observe them for signs that they need shunt placement. Total resection of posterior fossa tumors should restore the CSF pathway from the third ventricle to subarachnoid space through the sylvian aqueduct and the fourth ventricle; however, secondary adhesions around the sylvian aqueduct or outlets of the fourth ventricle may cause obstructive hydrocephalus.
In our series, six patients who underwent repeated ETVs were finally shunt independent (100%), and the mean interval between the first and second ETV was 25 months. Others have reported a 35% success rate with repeated ETV. The most common cause of failed ETV was occlusion of the stoma by scar tissue, and the mean interval between the first and second ETV was 12.8 months in a multicenter evaluation. 19 
Patient Age
Some authors have suggested that younger children may have less favorable outcomes than older patients after undergoing ETV to manage hydrocephalus; [1] [2] [3] 8, 9 our results support these findings. It is not clear why the difference between these two age groups exists; however, in a recent article investigators have postulated that younger children may have an immature subarachnoid space, leading to interference in CSF absorption. 21 In particular, patients younger than 1 year old may not be able to build a sufficient pressure gradient across the arachnoid granulations. Outcome of ETV in children with tumor-related hydrocephalus 3 
Effect of Previous Ventricular CSF Shunt Therapy
The role of previous ventricular shunt placement in the outcome of ETV is controversial. Teo and Jones 20 had reported statistically significantly higher success rates in the outcome of patients with previous ventricular shunt placement than in those without a previous shunt insertion (84% compared with 29%). They proposed a hypothesis that the shunt decreased the transmantle pressure (the pressure gradient between the ventricles and the subarachnoid space) and thereby allowed subarachnoid space to open and be mature. In addition, patients tend to be older because they have gone through a period of CSF shunting. 20 In contrast, the opposite outcome was observed in other reports. 17 
Postoperative Complications
Although ETV is generally considered a safe procedure, complication rates between 6 and 20% have been reported in several series. The majority of published instances were clinically insignificant, although several serious and fatal complications have been reported. [1] [2] [3] 8, 12, 18, 20 Complications related to the ETV procedure included intraoperative venous/arterial bleeding, seizures, CSF leakage, infection, oculomotor nerve palsy, bradycardia, temperature regulation disturbance, diabetes insipidus, syndrome of inappropriate antidiuretic hormone, basilar artery injury due to formation of a traumatic aneurysm or perforation, and subdural hematoma. [1] [2] [3] 7, 8, 12, 18, 20 Schroeder, et al., 18 reported the first death associated with ETV. A severe perimesencephalic-prepontine subarachnoid hemorrhage was identified on the postoperative computerized tomography scan. A review of the operative video showed that the Fogarty catheter had slipped posteriorly, leading to perforation of the floor of the third ventricle and injury to the basilar artery or perforating vessel. Therefore, to avoid this vascular injury, perforation of the floor of the third ventricle should be performed in the midline, halfway between the infundibular recess and the mammillary bodies, just behind the dorsum sellae.
7

CONCLUSIONS
Due to significant advances in technique and equipment, ETV is now a popular alternative to ventricular shunts for the treatment of obstructive hydrocephalus secondary to tumors in children. It obviates the placement of a foreign body such as a ventricular shunt, thus avoiding shunt-related complications such as malfunction, infection, and overdrainage.
